Virax Biolabs to Present at 19th World Immune Regulation Meeting
Provided By PR Newswire
Last update: Mar 5, 2025
LONDON, March 5, 2025 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that the company's management will present at the 19th World Immune Regulation Meeting (WIRM), which will take place March 12-15, 2025, in Davos, Switzerland.
Read more at prnewswire.com
